157 related articles for article (PubMed ID: 36277464)
1. α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis.
Lehrer S; Rheinstein PH
J Proteins Proteom; 2022 Jun; 13(2):109-115. PubMed ID: 36277464
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
Tehranian R; Montoya SE; Van Laar AD; Hastings TG; Perez RG
J Neurochem; 2006 Nov; 99(4):1188-96. PubMed ID: 16981894
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
Kim S; Park JM; Moon J; Choi HJ
Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.
Nagatsu T; Sawada M
J Neural Transm Suppl; 2007; (72):113-20. PubMed ID: 17982884
[TBL] [Abstract][Full Text] [Related]
6. L-Tyr-Induced Phosphorylation of Tyrosine Hydroxylase at Ser40: An Alternative Route for Dopamine Synthesis and Modulation of Na+/K+-ATPase in Kidney Cells.
Taveira-da-Silva R; da Silva Sampaio L; Vieyra A; Einicker-Lamas M
Kidney Blood Press Res; 2019; 44(1):1-11. PubMed ID: 30808844
[TBL] [Abstract][Full Text] [Related]
7. Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.
Wachtel SR; Bencsics C; Kang UJ
J Neurochem; 1997 Nov; 69(5):2055-63. PubMed ID: 9349551
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.
Jorge-Finnigan A; Kleppe R; Jung-Kc K; Ying M; Marie M; Rios-Mondragon I; Salvatore MF; Saraste J; Martinez A
J Biol Chem; 2017 Aug; 292(34):14092-14107. PubMed ID: 28637871
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine Hydroxylase and DOPA Decarboxylase Are Associated With Pupal Melanization During Larval-Pupal Transformation in
Wang Q; Zhong L; Wang Y; Zheng S; Bian Y; Du J; Yang R; Liu W; Qin L
Front Physiol; 2022; 13():832730. PubMed ID: 35464097
[TBL] [Abstract][Full Text] [Related]
10. Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase.
Flydal MI; Kråkenes TA; Tai MDS; Tran MPA; Teigen K; Martinez A
Biochimie; 2021 Apr; 183():126-132. PubMed ID: 33309753
[TBL] [Abstract][Full Text] [Related]
11. Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review.
Nezu M; Hirotsu Y; Amemiya K; Tateno T; Takizawa S; Inoue M; Mochizuki H; Hosaka K; Chik C; Oyama T; Omata M
Intern Med; 2023 Jul; 62(13):1895-1905. PubMed ID: 36384901
[TBL] [Abstract][Full Text] [Related]
12. Genes for human catecholamine-synthesizing enzymes.
Nagatsu T
Neurosci Res; 1991 Oct; 12(2):315-45. PubMed ID: 1684650
[TBL] [Abstract][Full Text] [Related]
13. Current status of tyrosine hydroxylase in management of Parkinson's disease.
Feve AP
CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
Nagatsu T; Nagatsu I
J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
[TBL] [Abstract][Full Text] [Related]
15. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy.
Zhong XH; Haycock JW; Shannak K; Robitaille Y; Fratkin J; Koeppen AH; Hornykiewicz O; Kish SJ
Mov Disord; 1995 Jan; 10(1):10-7. PubMed ID: 7885342
[TBL] [Abstract][Full Text] [Related]
16. Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells.
Liu D; Jin L; Wang H; Zhao H; Zhao C; Duan C; Lu L; Wu B; Yu S; Chan P; Li Y; Yang H
Neurochem Res; 2008 Jul; 33(7):1401-9. PubMed ID: 18357527
[TBL] [Abstract][Full Text] [Related]
17. Appearance of tyrosine hydroxylase, aromatic amino-acid decarboxylase, dopamine beta-hydroxylase and phenylethanolamine N-methyltransferase during the ontogenesis of the adrenal medulla: an immunohistochemical study in the rat.
Verhofstad AA; Hökfelt T; Goldstein M; Steinbusch HW; Joosten HW
Cell Tissue Res; 1979 Aug; 200(1):1-13. PubMed ID: 40700
[TBL] [Abstract][Full Text] [Related]
18. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines.
Baptista MJ; O'Farrell C; Daya S; Ahmad R; Miller DW; Hardy J; Farrer MJ; Cookson MR
J Neurochem; 2003 May; 85(4):957-68. PubMed ID: 12716427
[TBL] [Abstract][Full Text] [Related]
19. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.
Peng X; Tehranian R; Dietrich P; Stefanis L; Perez RG
J Cell Sci; 2005 Aug; 118(Pt 15):3523-30. PubMed ID: 16030137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
